ACS Appl Mater Interfaces, 2020, 12, 51, 56874-56885.
Y. Du, H. Sun, F. Lux, et al.
Archives Publications 2020
Three-dimensionnal quantitative MRI of aerosolized gadolinium-based nanoparticles and contrast agents in isolated ventilated porcine lungs
Magn. Reson. Med., 2020, 83, 1774-172.
Y. Crémillieux, Y. Montigaud, C. Bal, et al.
Human serum albumin in the presence of AGuIX nanoagents: structure stabilization without direct interaction
Int. J. Mol. Sci., 2020, 21, 4673.
X. Yang, M. Bolsa-Ferruz, L. Marichal, et al.
Nebulised gadolinium-based nanoparticles for a multimodal approach : quantitative and qualitative lung distribution using magnetic resonance and scintigraphy imaging in solated ventilated porcine lungs
Int. J. Nanomedicine, 2020, 15, 7251-7262.
Y. Montigaud, J. Pourchez, L. Leclerc, et al.
PET-MRI nanoparticles imaging of blood-brain barrier damage and modulation after stroke reperfusion
Brain Communications, 2020, 2, fcaa193.
J. Debatisse, O. Fakur Eker, O. Wateau, et al.
Anti-MUC1- C Antibody – conjugated nanoparticles potentiate the efficacy of fractionated radiation therapy
Int. J. Radiat. Oncol. Biol. Phys., 2020, 20, 6223.
A. Detappe, C. Mathieu, C. Jin, et al.
Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective
Science Advances, 2020, 6, eaay5279.
C. Verry, S. Dufort, B. Lemasson, et al.
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: from animal to human with theranostic AGuIX® nanoparticles
Theranostics, 2020, 10, 1319-1331.
G. Bort, F. Lux, S. Dufort, et al.